Novartis New Organizational Model
2
Combining R&D portfolio management, strategy and business
development to strengthen pipeline with high value medicines
FROM: Strategy and portfolio functions
across organization
TO: Single unit driving growth + enterprise-wide
prioritization of internal and external innovation
1
Portfolio
Management
2 Strategy
3
M&A and
BD&L
Chief Executive
Officer
Pharma
Oncology
GDD & NIBR
In scope
Out of scope
Chief Strategy &
Growth Officer
Corporate
Strategy
Portfolio
Analytics/
Management
Business
Development¹
Strategic
Competitive
Intelligence
Deliver high value assets (internal and external) to drive consistent above peer median growth
1. Incl. small scale M&As; large scale M&A remaining with Finance
9
NOVARTIS NEW ORGANIZATIONAL MODEL | APRIL 04, 2022 | NOVARTIS INVESTOR PRESENTATION
NOVARTIS | Reimagining MedicineView entire presentation